OptimizeRx Secures $35 Million Senior Credit Facility to Fuel Growth

OptimizeRx (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility comprises a $25 million term loan and a $10 million revolving credit facility, which was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction. This move is expected to bolster the company's financial flexibility and support its strategic initiatives.

The credit facility provides OptimizeRx with additional capital to invest in its innovative platform, which includes artificial intelligence-driven tools such as the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT). These tools enable life science brands to deliver timely, relevant, and hyper-local engagement with healthcare providers and patients. By bridging the gap between HCP and DTC strategies, OptimizeRx empowers brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.

The announcement highlights the growing importance of digital health solutions in the pharmaceutical industry. As life sciences companies increasingly seek to leverage technology to improve patient engagement and outcomes, OptimizeRx is well-positioned to capitalize on this trend. The company's commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time.

Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world's leading pharmaceutical and life sciences companies to transform the healthcare landscape. For more information, visit www.optimizerx.com. The full announcement is available at https://ibn.fm/G0Fj3.